Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Ali Noroozi Aghideh"'
Autor:
Adel Naimi, Rebar N. Mohammed, Ahmed Raji, Supat Chupradit, Alexei Valerievich Yumashev, Wanich Suksatan, Mohammed Nader Shalaby, Lakshmi Thangavelu, Siavash Kamrava, Navid Shomali, Armin D. Sohrabi, Ali Adili, Ali Noroozi-Aghideh, Ehsan Razeghian
Publikováno v:
Cell Communication and Signaling, Vol 20, Iss 1, Pp 1-31 (2022)
Abstract The main breakthrough in tumor immunotherapy was the discovery of immune checkpoint (IC) proteins, which act as a potent suppressor of the immune system by a myriad of mechanisms. After that, scientists focused on the immune checkpoint molec
Externí odkaz:
https://doaj.org/article/a42a511ba4384466874a9dc6537c72e4
Autor:
Sina Ahmadianfar, Nahid Mehrabi, Saeed Mohammadi, Ali Sobhanizadeh, Alireza Moradabadi, Ali Noroozi-Aghideh
Publikováno v:
Natural Product Sciences. 29:42-49
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b0edee55cd905a0b5e8bb2d0d49c85a
https://doi.org/10.20307/nps.2023.29.1.42
https://doi.org/10.20307/nps.2023.29.1.42
Publikováno v:
Cancer Treatment and Research Communications, Vol 28, Iss , Pp 100432- (2021)
Background: Acute Myeloid Leukemia (AML) is a group of hematologic diseases characterized by a variety of clinically important genetic alterations. Genetic mutations affecting the FMS-like receptor tyrosine kinase-3 (FLT3) and Wilm's tumor (WT-1) gen
Externí odkaz:
https://doaj.org/article/6eee760e07454ba189ce7f2abb6265f3
Autor:
Saeed Zaka Khosravi, Mohammadreza Moonesi, Alireza Moradabadi, Mohsen Rajaeinejad, Mohammad Foad Heidari, Ali Noroozi-Aghideh
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 23:125-130
Acute myeloid leukemia is caused by the clonal proliferation of undifferentiated myeloid hematopoietic precursors. AML prognosis is highly involved in the treatment response and is determined by mutations in several genes such as N-RAS. This study ai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80b89d2104986ea72cd636f92c12ec4c
https://doi.org/10.31557/apjcp.2022.23.1.125
https://doi.org/10.31557/apjcp.2022.23.1.125
Autor:
Akbar Dorgalaleh, Mehran Bahraini, Mahmood Shams, Fereshteh Parhizkari, Ali Dabbagh, Tohid Naderi, Aysan Fallah, Alieh Fazeli, Seyed Esmaeil Ahmadi, Amir Samii, Maryam Daneshi, Farshad Heydari, Shadi Tabibian, Behnaz Tavasoli, Ali Noroozi-Aghideh, Tahere Tabatabaei, Mohammad Saeed Gholami
Publikováno v:
Blood Reviews. 59:101029
Rare bleeding disorders (RBDs), including factor (F) I, FII, FV, FVII, combined FV and FVIII (CF5F8), FXI, FXIII and vitamin-K dependent coagulation factors (VKCF) deficiencies, are a heterogeneous group of hemorrhagic disorder with a variable bleedi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aec7312a45aa456c6763db91753ef95e
https://doi.org/10.1016/j.blre.2022.101029
https://doi.org/10.1016/j.blre.2022.101029
Autor:
Atefeh Entezari, Ali Hassanzadeh, Adel Naimi, Mahmoud Vahidi, Ali Noroozi-Aghideh, Yoda Yaghoubi, Majid Zamani
Publikováno v:
Annals of Cancer Research and Therapy. 29:96-101
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a1167f9f808b5c8fb5ccd40cac79aa1
https://doi.org/10.4993/acrt.29.96
https://doi.org/10.4993/acrt.29.96
Autor:
Adel Naimi, Rebar N. Mohammed, Ahmed Raji, Supat Chupradit, Alexei Valerievich Yumashev, Wanich Suksatan, Mohammed Nader Shalaby, Lakshmi Thangavelu, Siavash Kamrava, Navid Shomali, Armin D. Sohrabi, Ali Adili, Ali Noroozi-Aghideh, Ehsan Razeghian
Publikováno v:
Cell communication and signaling : CCS. 20(1)
The main breakthrough in tumor immunotherapy was the discovery of immune checkpoint (IC) proteins, which act as a potent suppressor of the immune system by a myriad of mechanisms. After that, scientists focused on the immune checkpoint molecules main
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93268c93985d12e9a3b5501e65095dae
https://pubmed.ncbi.nlm.nih.gov/35392976
https://pubmed.ncbi.nlm.nih.gov/35392976
Autor:
Mohammadreza Moonesi, Saeed Zaka Khosravi, Alireza Moradabadi, Mohsen Rajaeinejad, Mohammad Foad Heidari, Golnoosh Mahjub, Ali Noroozi-Aghideh
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 23(7)
Acute myeloid leukemia (AML) is caused by abnormal gene expression following mutations. Many of the mutations in AML lead to gene instability and poor response to treatment. Among these mutations, DNMT3A mutation is exceedingly important due to its m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::056c21f8be1dd3f862a0a4b98ac6c286
https://pubmed.ncbi.nlm.nih.gov/35901322
https://pubmed.ncbi.nlm.nih.gov/35901322
Publikováno v:
Journal of Blood Medicine. 10:235-241
Background The Janus kinase 2 (JAK2) has an important role in the intracellular signaling in normal and neoplastic cells. JAK2 mutation, called JAK2 V617F, is frequently found in Philadelphia chromosome-negative myeloproliferative neoplasms. We aimed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::623e05d87b1ea404312c1e5d81e344cf
https://doi.org/10.2147/jbm.s204222
https://doi.org/10.2147/jbm.s204222
Publikováno v:
World Journal of Stem Cells
Umbilical cord blood (UCB) is a valuable source of hematopoietic stem cells (HSCs) and potential alternative for bone marrow transplantation for patients who lack human leukocyte antigen (HLA)-matched donors. The main practical advantages of UCB over
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7cc200deec7f79ac65770397b71f38f
https://doi.org/10.4252/wjsc.v11.i2.73
https://doi.org/10.4252/wjsc.v11.i2.73